The mushroom Agaricus blazei (Ab) has been widely used in folk medicine to treat various diseases including cancer. No information is available on its possible protective effects on the development of colon cancer. The potential blocking effect of Ab intake on the initiation stage of colon carcinogenesis was investigated in a short-term (4-week) bioassay using aberrant crypt foci (ACF) as biomarker. Male Wistar rats were given four subcutaneous injections of the carcinogen 1,2-dimethylhydrazine (DMH, 40 mg/kg bw, twice a week), during 2 weeks to induce ACF. The diet containing Ab at 5% was given 2 weeks before and during carcinogen treatment to investigate the potential beneficial effects of this edible mushroom on DMH-induced ACF. All groups were killed at the end of the fourth week. The colons were analyzed for ACF formation in 1% methylene blue whole-mount preparations and for cell proliferation in histological sections immunohistochemically stained for the proliferating cell nuclear antigen (PCNA). All DMH-treated rats developed ACF mainly in the middle and distal colon. Agaricus blazei intake at 5% did not alter the number of ACF induced by DMH or the PCNA indices in the colonic mucosa. Thus, the results of the present study did not confirm a chemopreventive activity of Ab on the initiation stage of rat colon carcinogenesis.
1 Potter JD . Colorectal cancer: molecules and populations . J Natl Cancer Inst1999; 91: 916 – 932 .
2.
2 Willett WC . Diet and cancer: one view at the start of the millennium . Cancer Epidemiol Biomarkers Prev2001; 10: 3 – 8 .
3.
3 Bingham S Riboli E . Diet and cancer – the european prospective investigation into cancer and nutrition . Nat Rev Cancer2004; 4: 206 – 215 .
4.
4 Kohno H . Prevention of colonic preneoplastic lesions by the β-cryptoxanthin and hesperidin rich powder prepared from Citrus ushiu Marc. Juice in male F344 rats . J Toxicol Pathol1999; 12: 209 – 215 .
5.
5 Tanaka T . Inhibition of azoxymethane-induced colon carcinogenesis in male F344 rats by the citrus limonoids obacunone and limonin . Carcinogenesis2000; 22: 193 – 198 .
6.
6 Wargovich MJ . Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression . Carcinogenesis2000; 21: 1149 – 1155 .
7.
7 Sengupta A Ghosh S Das S . Modulatory influence of garlic and tomato on cyclooxygenase-2 activity, cell proliferation and apoptosis during azoxymethane induced colon carcinogenesis in the rat . Cancer Lett2004; 208: 127 – 136 .
8.
8 Taché S Ladam A Corpet DE . Chemoprevention of aberrant crypt foci in the colon of rats by dietary onion . Eur J Cancer2007; 43: 454 – 458 .
10 Bird RP Good CK . The significance of aberrant crypt foci in understanding the patogenesis of colon cancer . Toxicol Lett2000; 112–113: 395 – 402 .
11.
11 Corpet DE Tache S . Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency . Nutr Cancer2002; 43: 1 – 21 .
12.
12 Mori H . Significance and role of early-lesions in experimental colorectal carcinogenesis . Chem Biol Interact2005; 155: 1 – 9 .
13.
13 Rodrigues MAM . Aberrant crypt foci and colon cancer: comparison between a short and medium-term bioassay for colon carcinogenesis using dimethylhydrazine in Wistar rats . Braz J Med Biol Res2002; 35: 351 – 355 .
14.
14 Rudolph RE . Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans . Cancer Epidemiol Biomakers Prev2005; 14: 605 – 608 .
15.
15 Stevens RG Swede H Rosenberg DW . Epidemiology of colonic aberrant crypt foci: review and analysis of existing studies . Cancer Lett2007; 252: 171 – 183 .
16.
16 Chang R . Functional properties of edible mushrooms . Nutr Rev1996; 54: 91 – 93 .
17.
17 Borchers AT Keen CL Gershwin ME . Mushrooms, tumors, and immunity: an update . Exp Biol Med2004; 229: 393 – 406 .
18.
18 Ribeiro LR Mantovani MS Ribeiro DA Salvadori DMF . Brazilian natural dietary components (annatto, propolis and mushrooms) protecting against mutation and cancer . Hum Exp Toxicol2006; 25: 267 – 272 .
19.
19 Mizuno T Saito H Nishitoba T Kawagishi H . Antitumor-active substances from mushrooms . Food Rev Int1995; 11: 23 – 61 .
20.
20 Wasser SP Weiss AL . Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: modern perspective . Crit Rev Immunol1999; 19: 65 – 96 .
21.
21 Mizuno T . Antitumor activity and some properties of water-soluble polysaccharides from “Himematsutake”, the fruiting body of Agaricus blazei Murill . Agric Biol Chem1990; 54: 2889 – 2896 .
22.
22 Fujimiya Y Suzuki Y Takakura R Ebina T . Tumor-specific cytocidal and immunopotentiating effects of relatively low molecular weigh products derived from the basidiomycetes, Agaricus blazei Murill . Anticancer Res1999; 19: 113 – 118 .
24 Takaku T Kimura Y Okuda H . Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action . J Nutr2001; 131: 1409 – 1413 .
25.
25 Kobayashi H . Suppresing effects of daily oral supplementation of beta-glucan extracted from Agaricus blazei Murill on spontaneous and peritoneal disseminated metastasis in mouse model . J Cancer Res Clin Oncol2005; 131: 527 – 538 .
26.
26 Izawa S Inoue Y . A screening system for antioxidants using thioredoxin-deficient yeast: discovery of thermostable antioxidant activity from Agaricus blazei Murill . Appl Microbiol Biotechnol2004; 64: 537 – 542 .
27.
27 Ker Y-B . Antioxidant capability of polysaccharides fractionated from submerge-cultured Agaricus blazei mycelia . J Agric Food Chem2005; 53: 7052 – 7058 .
28.
28 Kuroiwa Y . Lack of subchronic toxicity of an aqueous extract of Agaricus blazei Murrill in F344 rats . Food Chem Toxicol2005; 43: 1047 – 1053 .
29.
29 Lee IP Kang BH Roth JK Kim JR . Lack of carcinogenicity of lyophilized Agaricus blazei Murill in a F344 rat two year bioassay . Food Chem Toxicol2008; 46: 87 – 95 .
30.
30 Potten CS Li YQ O’Connor PJ Winton DJ . A possible explanation for the differential cancer incidence in the intestine, based on distribution of the cytotoxic effects of carcinogens in the murine large bowel . Carcinogenesis1992; 13: 2305 – 2312 .
31.
31 Park HS Goodland R Wright NA . The incidence of aberrant crypt foci and colonic carcinoma in dimethylhydrazine-treated rats varies in a site- specific manner and depends on tumor histology . Cancer Res1997; 57: 4507 – 4510 .
32.
32 Jackson PE . Associations between tissue-specific DNA alkylation, DNA repair and cell proliferation in the colon and colon tumour yield in mice treated with 1,2-dimethylhydrazine . Carcinogenesis2003; 24: 527 – 533 .
33.
33 Chang WL Chapkin RS Lupton JR . Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis . Carcinogenesis1997; 18: 721 – 730 .
34.
34 Pinheiro F . Chemoprevention of preneoplastic liver foci development by dietary mushroom Agaricus blazei Murrill in the rat . Food Chem Toxicol2003; 41: 1543 – 1550 .
35.
35 Gamberini M . Contribution of hydrazines-derived alkyl radicals to cytotoxicity and transformation induced in normal c-myc-overexpressing mouse fibroblasts . Carcinogenesis1998; 19: 147 – 155 .
36.
36 Delmanto RD . Antimutagenic effect of Agaricus blazei Murrill mushroom on the genotoxicity induced by cyclophosphamide . Mutat Res2001; 496: 15 – 21 .
37.
37 Menoli RCRN . Antimutagenic effects of the mushroom Agaricus blazei Murrill extracts on V79 cells . Mutat Res2001; 496: 5 – 13 .
38.
38 Martins de Oliveira J . Anti-gentoxic effects of aqueous extracts of sun mushroom (Agaricus blazei Murrill lineage 99/26) in mammalian cells in vitro . Food Chem Toxicol2002; 40: 1775 – 1780 .
39.
39 Bellini MF . Antigenotoxicity of Agaricus blazei mushroom organic and aqueous extracts in chromosomal aberration and cytokinesis block micronucleus assays in CHO-k1 and HTC cells . Toxicol in Vitro2006; 20: 355 – 360 .
40.
40 Zheng Y . Prevention by retinoids of azoxymethane-induced tumors and aberrant crypt foci and their modulation of cell proliferation in the colon of rats . Carcinogenesis1997; 18: 2119 – 2125 .
